{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:11:22Z","timestamp":1769631082763,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"name":"University of Bern"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologie"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>Dieser Beitrag gibt einen praxisnahen \u00dcberblick dar\u00fcber, wie thorakale Erkrankungen zuverl\u00e4ssig anhand kleiner Pr\u00e4parate beurteilt werden k\u00f6nnen. Er zeigt, wie sich zytologische und histologische Verfahren sinnvoll erg\u00e4nzen, warum eine sorgf\u00e4ltige Pr\u00e4analytik und Materialsteuerung entscheidend sind und wie Zusatzuntersuchungen mit Augenma\u00df eingesetzt werden, um Gewebe zu schonen. Der Artikel greift aktuelle Entwicklungen wie digitale Auswerteverfahren auf und formuliert alltagstaugliche Empfehlungen\u00a0\u2013 inklusive typischer Fallstricke und Hinweise zur Ergebnisinterpretation.<\/jats:p>","DOI":"10.1007\/s00292-025-01521-y","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T09:55:18Z","timestamp":1765187718000},"page":"63-72","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostik von Lungenerkrankungen anhand kleiner Pr\u00e4parate","Diagnostics of lung diseases based on small specimens"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8993-3410","authenticated-orcid":false,"given":"Tereza","family":"Losmanova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekkehard","family":"Hewer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Berezowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"issue":"2","key":"1521_CR1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/his.14801","volume":"82","author":"O Savari","year":"2023","unstructured":"Savari\u00a0O, Aldana\u00a0CF, Chang\u00a0JC et\u00a0al (2023) Non-small cell lung carcinomas with diffuse co-expression of TTF1 and p40: Clinicopathologic and genomic features of 14 rare biphenotypic tumors. Histopathology 82(2):242\u2013253","journal-title":"Histopathology"},{"issue":"6","key":"1521_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1159\/000517078","volume":"65","author":"MSI Mansour","year":"2021","unstructured":"Mansour\u00a0MSI, Lindquist\u00a0KE, Seidal\u00a0T et\u00a0al (2021) PD-L1 Testing in Cytological Non-Small Cell Lung Cancer Specimens: A\u00a0Comparison with Biopsies and Review of the Literature. Acta Cytol 65(6):501\u2013509","journal-title":"Acta Cytol"},{"issue":"5","key":"1521_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/cncy.22137","volume":"127","author":"D Jain","year":"2019","unstructured":"Jain\u00a0D, Nambirajan\u00a0A, Borczuk\u00a0A et\u00a0al (2019) Immunocytochemistry for Predictive Biomarker Testing in Lung Cancer Cytology. Cancer Cytopathol 127(5):325\u2013339","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"1521_CR4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000543867","volume":"69","author":"D Jain","year":"2025","unstructured":"Jain\u00a0D, Satapathy\u00a0S, Bubendorf\u00a0L (2025) Diagnostic and Predictive Immunocytochemistry in Lung Cancer. Acta Cytol 69(1):69\u201376","journal-title":"Acta Cytol"},{"issue":"7","key":"1521_CR5","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41379-018-0006-x","volume":"31","author":"S Roy-Chowdhuri","year":"2018","unstructured":"Roy-Chowdhuri\u00a0S, Mehrotra\u00a0M, Bolivar\u00a0AM et\u00a0al (2018) Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling. Mod Pathol 31(7):1036\u20131045","journal-title":"Mod Pathol"},{"issue":"9","key":"1521_CR6","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","volume":"185","author":"KC Meyer","year":"2012","unstructured":"Meyer\u00a0KC, Raghu\u00a0G, Baughman\u00a0RP et\u00a0al (2012) An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease. Am J Respir Crit Care Med 185(9):1004\u20131014","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1521_CR7","doi-asserted-by":"publisher","first-page":"e000443","DOI":"10.1136\/bmjresp-2019-000443","volume":"6","author":"LK Troy","year":"2019","unstructured":"Troy\u00a0LK, Grainge\u00a0C, Corte\u00a0T et\u00a0al (2019) Cryobiopsy versus open lung biopsy in the diagnosis of interstitial lung disease (COLDICE): protocol of a\u00a0multicentre study. BMJ Open Respir Res 6(1):e443","journal-title":"BMJ Open Respir Res"},{"issue":"9","key":"1521_CR8","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu\u00a0G, Remy-Jardin\u00a0M, Richeldi\u00a0L et\u00a0al (2022) Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med 205(9):e18\u2013e47","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"1521_CR9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.5858\/arpa.2017-0114-SA","volume":"142","author":"D Jain","year":"2018","unstructured":"Jain\u00a0D, Allen\u00a0TC, Aisner\u00a0DL et\u00a0al (2018) Rapid On-Site Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A\u00a0Perspective From Members of the Pulmonary Pathology Society. Arch Pathol Lab Med 142(2):253\u2013262","journal-title":"Arch Pathol Lab Med"},{"key":"1521_CR10","doi-asserted-by":"publisher","first-page":"104638","DOI":"10.1016\/j.ijmedinf.2021.104638","volume":"157","author":"Y Tao","year":"2022","unstructured":"Tao\u00a0Y, Cai\u00a0Y, Fu\u00a0H, Song\u00a0L, Xie\u00a0L, Wang\u00a0K (2022) Automated interpretation and analysis of bronchoalveolar lavage fluid. Int J Med Inf 157:104638","journal-title":"Int J Med Inf"},{"key":"1521_CR11","unstructured":"Lungenkarzinome | Neues WHO Reporting System for Lung Cytopathology | springermedizin.de https:\/\/www.springermedizin.de\/lungenkarzinome\/die-pathologie\/neues-who-reporting-system-for-lung-cytopathology\/51147546. Zugegriffen: 29. Okt. 2025"},{"key":"1521_CR12","unstructured":"ICCR Tumours of the Lung\u2014Small Diagnostic and Cytopathological Specimens. https:\/\/www.iccr-cancer.org\/datasets\/published-datasets\/thorax\/tumours-of-the-lung-small-diagnostic-and-cytopathological-specimens\/. Zugegriffen: 29. Okt. 2025"},{"issue":"2","key":"1521_CR13","doi-asserted-by":"publisher","first-page":"2000206","DOI":"10.1183\/13993003.00206-2020","volume":"56","author":"N Adderley","year":"2020","unstructured":"Adderley\u00a0N, Humphreys\u00a0CJ, Barnes\u00a0H et\u00a0al (2020) Bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis: a\u00a0systematic review and meta-analysis. Eur Respir\u00a0J 56(2):2000206","journal-title":"Eur Respir J"},{"issue":"3","key":"1521_CR14","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","volume":"202","author":"G Raghu","year":"2020","unstructured":"Raghu\u00a0G, Remy-Jardin\u00a0M, Ryerson\u00a0CJ et\u00a0al (2020) Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med 202(3):e36\u2013e69","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1521_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12890-024-03428-5","volume":"25","author":"T Zannese","year":"2025","unstructured":"Zannese\u00a0T, Viallard\u00a0JF, Sridi-Cheniti\u00a0S et\u00a0al (2025) CD4\/CD8 T\u2011cell ratio in bronchoalveolar lavage fluid as a\u00a0marker of sarcoidosis severity: a\u00a0retrospective study. BMC Pulm Med 25(1):227","journal-title":"BMC Pulm Med"},{"issue":"12","key":"1521_CR16","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1183\/09031936.97.10122699","volume":"10","author":"U Costabel","year":"1997","unstructured":"Costabel\u00a0U (1997) CD4\/CD8 ratios in bronchoalveolar lavage fluid: of value for diagnosing sarcoidosis? Eur Respir\u00a0J 10(12):2699\u20132700","journal-title":"Eur Respir J"},{"key":"1521_CR17","unstructured":"BlueBooksOnline https:\/\/tumourclassification.iarc.who.int\/chapters\/35. Zugegriffen: 29. Okt. 2025"},{"issue":"3","key":"1521_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jtho.2018.12.005","volume":"14","author":"Y Yatabe","year":"2019","unstructured":"Yatabe\u00a0Y, Dacic\u00a0S, Borczuk\u00a0AC et\u00a0al (2019) Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer. J\u00a0Thorac Oncol 14(3):377\u2013407","journal-title":"J Thorac Oncol"},{"issue":"6","key":"1521_CR19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jtho.2022.02.013","volume":"17","author":"D Jain","year":"2022","unstructured":"Jain\u00a0D, Nambirajan\u00a0A, Chen\u00a0G et\u00a0al (2022) NSCLC Subtyping in Conventional Cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group Survey to Determine Specific Cytomorphologic Criteria for Adenocarcinoma and Squamous Cell Carcinoma. J\u00a0Thorac Oncol 17(6):793\u2013805","journal-title":"J Thorac Oncol"},{"issue":"11","key":"1521_CR20","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/j.humpath.2015.07.012","volume":"46","author":"SY Chang","year":"2015","unstructured":"Chang\u00a0SY, Keeney\u00a0M, Law\u00a0M et\u00a0al (2015) Detection of human papillomavirus in non\u2013small cell carcinoma of the lung. Hum Pathol 46(11):1592\u20131597","journal-title":"Hum Pathol"},{"issue":"2","key":"1521_CR21","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtho.2016.12.004","volume":"12","author":"E Thunnissen","year":"2017","unstructured":"Thunnissen\u00a0E, Borczuk\u00a0AC, Flieder\u00a0DB et\u00a0al (2017) The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a\u00a0Demanding Set of Cases. J\u00a0Thorac Oncol 12(2):334\u2013346","journal-title":"J Thorac Oncol"},{"issue":"21","key":"1521_CR22","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1158\/1078-0432.CCR-22-1115","volume":"28","author":"CA Febres-Aldana","year":"2022","unstructured":"Febres-Aldana\u00a0CA, Chang\u00a0JC, Ptashkin\u00a0R et\u00a0al (2022) Rb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a\u00a0Description of a\u00a0Distinct Rb-Proficient Subset. Clin Cancer Res 28(21):4702\u20134713","journal-title":"Clin Cancer Res"},{"issue":"9","key":"1521_CR23","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jtho.2022.06.004","volume":"17","author":"MK Baine","year":"2022","unstructured":"Baine\u00a0MK, Febres-Aldana\u00a0CA, Chang\u00a0JC et\u00a0al (2022) POU2F3 in SCLC: Clinicopathologic and genomic analysis with a\u00a0focus on its diagnostic utility in neuroendocrine-low SCLC. J\u00a0Thorac Oncol 17(9):1109\u20131121","journal-title":"J Thorac Oncol"},{"key":"1521_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/his.15076","volume":"84","author":"S Berezowska","year":"2024","unstructured":"Berezowska\u00a0S, Maillard\u00a0M, Keyter\u00a0M, Bisig\u00a0B (2024) Pulmonary squamous cell carcinoma and lymphoepithelial carcinoma\u2014morphology, molecular characteristics and differential diagnosis. Histopathology 84:32\u201349","journal-title":"Histopathology"}],"container-title":["Die Pathologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-025-01521-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-025-01521-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-025-01521-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T08:23:44Z","timestamp":1769588624000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-025-01521-y"}},"subtitle":["Zytologien und Biopsien","Biopsies and cytology"],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1521"],"URL":"https:\/\/doi.org\/10.1007\/s00292-025-01521-y","relation":{},"ISSN":["2731-7188","2731-7196"],"issn-type":[{"value":"2731-7188","type":"print"},{"value":"2731-7196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"2 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"T.\u00a0Losmanova\n                      : A.\u00a0Finanzielle Interessen: Alfred und Annelise Sutter-St\u00f6ttner Stiftung \u2013\u00a0F\u00f6rderung junger Forscher, Stipendium.\u00a0\u2013 Advisory Board 13.05.2025 AstraZeneca \u2013\u00a0Honorar; Referent Update Lungenkarzinom (NSCLC & SCLC) 04.03.2025\u00a0\u2013 Honorar; Referent Indica Labs 2023 und 2024 \u2013\u00a0Reisekostenerstattung.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: angestellte Fach\u00e4rztin: Institut f\u00fcr Gewebemedizin und Pathologie, Bern, Schweiz | Mitgliedschaft in Organisationen: | Pulmonary Pathology Society (PPS) \u2013\u00a0Regular Member, Swiss Society of Pathology (SGPath), Swiss Lung Pathology Group (SLPG)\u00a0\u2013 Regular Member, Swiss Digital Pathology Group (SDiPath) \u2013\u00a0Regular Member.\n                      M.\u00a0Maillard\n                      : A.\u00a0Finanzielle Interessen: M.\u00a0Maillard gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Pathologin am Universit\u00e4tsspital Lausanne (CHUV) | Lehrerin f\u00fcr Humanmedizin an der Universit\u00e4t Lausanne | Mitgliedschaften: Schweizerische Gesellschaft f\u00fcr Pathologie, Schweizerischen Gesellschaft f\u00fcr Zytologie.\n                      E.\u00a0Hewer\n                      : A.\u00a0Finanzielle Interessen: E.\u00a0Hewer gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: angestellter Pathologe und Professor f\u00fcr Pathologie an der Universit\u00e4t Lausanne | Vorstandsmitglied Schweizerische Gesellschaft f\u00fcr Pathologie.\n                      S.\u00a0Berezowska\n                      : A.\u00a0Finanzielle Interessen: Ich habe keine Forschungsf\u00f6rderung von der Industrie erhalten. Forschungsf\u00f6rderung, unmittelbar finanzielle Mittel: \u201eMultiple lung tumor nodules: establishing cost effective | molecular and digital pathology methods to separate multiple primary lung cancers from intrapulmonary | metastases\u201c (PI; 2025\u20132028) ISREC TANDEM Grant; \u201eRecommendations on the evaluation of lymph nodes resected after neoadjuvant therapy in non-small cell lung carcinoma.\u201c (PI; 2025\u201326) IASLC Committee Project Funding; \u201eConstruction of a\u00a0tissue microarray for evaluation of grading criteria in primary resected squamous cell carcinomas of the lung\u201c (PI; 2024) Stiftung zur Krebsbek\u00e4mpfung; \u201eIntegrative molecular characterization uncovers new therapeutic rationales for malignant pleural mesothelioma\u201c (Co-Appl.; PI PD Dr. Ren-Wang Peng, 2020\u20132023); Swiss Cancer League; \u201eMolecular epidemiology of lung cancer brain metastases\u201c (PI, 2019\u20132023) Swiss Cancer League.\u00a0\u2013 alles als Honorar an die Institution (CHUV, Institut f\u00fcr Pathologie) und Reisekostenerstattung: | Springer: Webinar, medtis GmbH: Referentin, MSD: Advisory Board, MERCK: Advisory Board, PEAK Medicals: Referentin, Daiichi-Sankyo: Advisory Board. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: angestellte Chef\u00e4rztin: Institut f\u00fcr Pathologie, CHUV, Lausanne | Professur: Universit\u00e4t Lausanne | Mitgliedschaft in Organisationen: | International Association for the Study of Lung Cancer (IASLC)\u00a0\u2013 Pathology Committee Member, Pulmonary Pathology Society (PPS) \u2013\u00a0Member of the Board 2024\u20132026 (Secretary), International Academy of Pathology (IAP), German Division\u00a0\u2013 Member of the Board and Educational Committee, European Society of Pathology (ESP), Chair of Working Group \u201ePulmonary\u201c (2025\u20132026), German Society of Pathology (DGP), Former Speaker der Working Group Thoracic Pathology, SAKK project group Lung Cancer, Swiss Society of Pathology (SGPath), Swiss Lung Pathology Group (SLPG), Swiss Digital Pathology Group (SDiPath).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}